Mascardo, Felicisimo L.
HRN: 21-45-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/06/2022
06/13/2022
IV
1.5
Q6
Multiple STI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes